Pfizer's rare heart disease drug succeeds in late-stage study


Pfizer Inc said on Thursday its drug for a rare and fatal disease associated with progressive heart failure met the main goal in a late-stage study. FILE PHOTO: A company logo is seen at a Pfizer office in Dublin, Ireland November 24, 2015.



from Biotech News